Other Events ·
Nasdaq Hearings Panel denies OSR Health's appeal and orders delisting for non-compliance with $1.00 minimum bid price
OSRHWOSR Health, Inc.
The Nasdaq Hearings Panel has denied OSR Health, Inc.'s request for continued listing and determined to delist the company's common stock and warrants from The Nasdaq Stock Market due to non-compliance with the $1.00 minimum bid price requirement. Trading was previously suspended on August 26, 2026, and securities now trade on the over-the-counter market under symbols OSRH and OSRHW. The company stated it chose not to pursue a reverse stock split during the compliance process and is evaluating strategic options to regain listing status, with an update expected by November 6, 2026. OSR Health operates as a global healthcare holding company advancing biomedical innovations in immuno-oncology, regenerative biologics, and medical device technologies.